Can we distinguish atypical primary brain lymphoma from glioblastoma multiforme by looking at the non-enhancing tumor?

被引：0
|
作者：
Fushimi, Yasutaka [1 ]
Nakajima, Satoshi [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan
来源：
EUROPEAN RADIOLOGY | 2023年 / 33卷 / 08期
关键词：
CENTRAL-NERVOUS-SYSTEM; DIFFERENTIATION;
D O I：
10.1007/s00330-023-09750-6
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：5355 / 5356
页数：2
相关论文
共 9 条
  • [1] Can we distinguish atypical primary brain lymphoma from glioblastoma multiforme by looking at the non-enhancing tumor?
    Yasutaka Fushimi
    Satoshi Nakajima
    European Radiology, 2023, 33 : 5355 - 5356
  • [2] Atypical Non-Enhancing Primary Central Nervous System Lymphoma
    Valenti, Erik
    Kong, Xiao-Tang
    NEUROLOGY, 2019, 92 (15)
  • [3] Diffusion restriction in a non-enhancing metastatic brain tumor treated with bevacizumab - recurrent tumor or atypical necrosis?
    Sivasundaram, Lakshmanan
    Hazany, Saman
    Wagle, Naveed
    Zada, Gabriel
    Chen, Thomas C.
    Lerner, Alexander
    Go, John L.
    D'Amore, Francesco
    Law, Meng
    Shiroishi, Mark S.
    CLINICAL IMAGING, 2014, 38 (05) : 724 - 726
  • [4] Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling
    Yu, Xiaojun
    Hong, Weiping
    Ye, Minting
    Lai, Mingyao
    Shi, Changzheng
    Li, Linzhen
    Ye, Kunlin
    Xu, Jiali
    Ai, Ruyu
    Shan, Changguo
    Cai, Linbo
    Luo, Liangping
    EUROPEAN RADIOLOGY, 2023, 33 (08) : 5357 - 5367
  • [5] Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling
    Xiaojun Yu
    Weiping Hong
    Minting Ye
    Mingyao Lai
    Changzheng Shi
    Linzhen Li
    Kunlin Ye
    Jiali Xu
    Ruyu Ai
    Changguo Shan
    Linbo Cai
    Liangping Luo
    European Radiology, 2023, 33 : 5357 - 5367
  • [6] PARAMETRIC MAPS OF CONTRAST AGENT DIFFUSION USING A NOVEL DIFFUSION-PERFUSION MODEL APPLIED TO DCE-MRI CAN DIFFERENTIATE NON-ENHANCING TUMOR FROM EDEMA IN HUMAN GLIOBLASTOMA
    Leu, Kevin
    Anh Tran
    Pope, Whitney
    Lai, Albert
    Nghiemphu, Phioanh
    Harris, Robert
    Woodworth, Davis
    Cloughesy, Timothy
    Ellingson, Benjamin
    NEURO-ONCOLOGY, 2014, 16
  • [7] Convolutional neural network can help differentiate FDG PET images of brain tumor between glioblastoma and primary central nervous system lymphoma
    Hirata, Kenji
    Takeuchi, Wataru
    Yamaguchi, Shigeru
    Kobayashi, Hiroyuki
    Terasaka, Shunsuke
    Toyonaga, Takuya
    Watanabe, Shiro
    Kobayashi, Kentaro
    Manabe, Osamu
    Kobashi, Keiji
    Shiga, Tohru
    Tamaki, Nagara
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [8] A radiomics approach to distinguish non-contrast enhancing tumor from vasogenic edema on multi-parametric pre-treatment MRI scans for Glioblastoma tumors
    Yadav, Ipsa
    Ismail, Marwa
    Statsevych, Volodymyr
    Hill, Virginia
    Correa, Ramon
    Ahluwalia, Manmeet
    Tiwari, Pallavi
    MEDICAL IMAGING 2022: COMPUTER-AIDED DIAGNOSIS, 2022, 12033
  • [9] How can we differentiate supratentorial tumor recurrence from postradiation imaging changes in children treated for primary malignant brain tumors?
    Zittoun, Jacob
    Dangouloff-Ros, Volodia
    Cardoen, Liesbeth
    Rutten, Caroline
    Bolle, Stephanie
    Alapetite, Claire
    Levy, Raphael
    Grevent, David
    Grill, Jacques
    Brisse, Herve J.
    Doz, Francois
    Blauwblomme, Thomas
    Beccaria, Kevin
    Charpy, Sarah
    Roux, Charles-Joris
    Varlet, Pascale
    Dufour, Christelle
    Puget, Stephanie
    Boddaert, Nathalie
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2023, 32 (02) : 173 - 183
1